AGGRESSIVE B-CELL NON-HODGKIN'S LYMPHOMA (NHL)

Clinical trials for AGGRESSIVE B-CELL NON-HODGKIN'S LYMPHOMA (NHL) explained in plain language.

Never miss a new study

Get alerted when new AGGRESSIVE B-CELL NON-HODGKIN'S LYMPHOMA (NHL) trials appear

Sign up with your email to follow new studies for AGGRESSIVE B-CELL NON-HODGKIN'S LYMPHOMA (NHL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New drug combo tested for Tough-to-Treat blood cancers

Disease control Completed

This early-stage study tested a new drug called PRT2527, both by itself and combined with other cancer drugs, in people with advanced blood cancers that had returned or stopped responding to standard treatments. The main goals were to find a safe dose and see if the treatments sh…

Matched conditions: AGGRESSIVE B-CELL NON-HODGKIN'S LYMPHOMA (NHL)

Phase: PHASE1 • Sponsor: Prelude Therapeutics • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

AGGRESSIVE B-CELL NON-HODGKIN'S LYMPHOMA (NHL)

Get alerted when new AGGRESSIVE B-CELL NON-HODGKIN'S LYMPHOMA (NHL) trials appear

New drug combo tested for Tough-to-Treat blood cancers